PRESS-NEWS.org - Press Release Distribution
PRESS RELEASES DISTRIBUTION

Long-haul COVID: Columbia physicians review what's known

2021-03-22
(Press-News.org) NEW YORK, NY (March 22, 2021)--The first year of the COVID-19 pandemic has taken the lives of millions of people around the world but has also left hundreds with lingering symptoms or completely new symptoms weeks after recovery.

Much is unknown about what causes these symptoms and how long they last. But with nearly 740,000 cases of COVID reported in New York City since last March--and 28 million in the United States--physicians are increasingly seeing these "long-haulers" in their practices.

"Over the course of the summer, we started getting a sense of what issues these people were having," says Ani Nalbandian, MD, a cardiology fellow at Columbia University Vagelos College of Physicians and Surgeons and first author of a new review of post-acute COVID-19.

"We felt that a review of all these possible issues would be important not only for health care providers but also for patients. It's important for patients to know that what they're experiencing may be a consequence of COVID-19 infection and that they are not alone in experiencing lingering effects of COVID-19 infection."

Nalbandian, along with co-first author Kartik Sehgal, MD, medical oncologist at Harvard Medical School and Dana Farber Cancer Institute, spearheaded the review effort, bringing together more than 30 experts from Columbia and other medical centers hit by the initial wave. The review summarizes what the physicians were seeing in their own patients and what others had reported in the literature. The experts represented a wide range of fields, including neurology, cardiology, and nephrology.

Nalbandian and Elaine Y. Wan, MD, the Esther Aboodi Assistant Professor of Medicine in Cardiology and Cardiac Electrophysiology at Columbia University, the review's senior author, discuss the symptoms that patients and providers should know about COVID-19 long haulers.

It's Not Just "Brain Fog"

Chest pain has been reported in up to 20% of COVID-19 survivors two months after recovery from the infection, COVID-19 can unveil previously unrecognized cases of diabetes, and a few percentage of patients experience strokes, pulmonary embolisms, and other complications from blood clots.

Wan's speciality is electrophysiology, and during the pandemic she and her colleagues published more than 10 articles about COVID and heart arrhythmias.

"Arrhythmias can lead to stroke, heart failure, and long-lasting damage to the heart," says, "and that's something that patients may not be aware of."

In addition, multiple organs may be affected simultaneously. "If you go to a cardiologist, the cardiologist may just focus on the heart," Nalbandian says. "But we need to think of the whole person since COVID is potentially affecting many organs, especially in those who have been hospitalized."

Everyone Is Vulnerable

Most people who experience long-term symptoms may have had health issues before contracting the virus or they developed very severe illness during COVID-19 infection.

"But really, any of these issues can happen to any patient who had COVID-19," says Wan. "For example, we've seen young patients without prior medical illness who developed autonomic dysfunction and fast heart rates after COVID-19. It's not just the most vulnerable who have issues after COVID."

"There really is a post-COVID syndrome and it doesn't always correlate with the severity of the acute COVID infection itself," says Nalbandian.

The majority of COVID patients never come to the hospital for treatment. "We may not be checking in on these patients with the same urgency, but they shouldn't be forgotten," she adds.

Symptoms Can Appear Weeks, Months after Recovery

"I have seen young patients, weeks even months after COVID-19 infection, and they've suddenly developed new onset of heart racing, palpitations, and chronic fatigue," says Wan.

Other patients complain weeks later of new chest discomfort or difficulty with decision making, memory, and concentration.

"When we think of COVID-19, we think of mostly a respiratory illness," Wan says. "But even after they've recovered from their respiratory illness, they may still have other clinical symptoms due to issues with other organ systems."

Patients Need Dedicated "COVID-19 Clinics"

"COVID-19 is the first infectious disease that I've come across that has such an effect on a wide variety of organs," Wan says. "It's changed my clinical practice. No matter what the patient comes in for, I now ask if they ever had COVID-19 infection. It changes the possible range of diagnoses."

"Based on this review, all of us recognized that there needs to be interdisciplinary care to treat patients longitudinally," says Nalbandian. "Care for patients with COVID-19 should not conclude at the time of hospital discharge."

To provide interdisciplinary care, health care systems should establish dedicated "COVID-19 clinics," similar to those now found in Italy.

Nalbandian says setting up such clinics in the United States has been difficult since physicians are still busy taking care of new COVID patients as subsequent waves come in. "Clinics could prioritize follow-up care for those at high risk for post-acute COVID-19 and those with the highest burden of persistent symptoms."

Patients Should Be Vocal

Nalbandian says many patients have complained that their doctors don't recognize that their symptoms may be related to COVID, and that's one reason she and her co-authors organized the review. "Here in New York, we're seeing patients who have been struggling for weeks and months looking for doctors who are knowledgeable," Nalbandian says. "Physicians should be attentive, legitimize patient concerns, and thoroughly document the symptoms."

Patients should not be afraid to be vocal about their symptoms. "Get in touch with your doctors even if you're not sure if your symptoms are lingering from your COVID infection," she says. "The situation is still fluid and we're learning more every month."

Join Patient Advocacy Groups and Clinical Trials

The work of new patient advocacy groups has helped identify persistent symptoms and was instrumental in highlighting the persistence of symptoms among those who didn't require hospitalization.

"Active engagement with these groups is crucial," Nalbandian says, "along with participation in clinical trials for longitudinal assessment."

Though the medical community now has a better grasp of the constellation of the long-term symptoms that occur after COVID, "we don't know the duration and the long term complications," Nalbandian adds.

"In order to learn more, we need to refer patients to trials, and we've listed many active research studies in our review.

"Health care providers are still overburdened taking care of patients with acute COVID, but that's a collective responsibility of the medical community at large."

INFORMATION:

Columbia University Irving Medical Center provides international leadership in basic, preclinical, and clinical research; medical and health sciences education; and patient care. The medical center trains future leaders and includes the dedicated work of many physicians, scientists, public health professionals, dentists, and nurses at the Vagelos College of Physicians and Surgeons, the Mailman School of Public Health, the College of Dental Medicine, the School of Nursing, the biomedical departments of the Graduate School of Arts and Sciences, and allied research centers and institutions. Columbia University Irving Medical Center is home to the largest medical research enterprise in New York City and State and one of the largest faculty medical practices in the Northeast. For more information, visit cuimc.columbia.edu or columbiadoctors.org.



ELSE PRESS RELEASES FROM THIS DATE:

Redox imaging allows measurement of drug responses in lab-grown cancer samples

Redox imaging allows measurement of drug responses in lab-grown cancer samples
2021-03-22
Organoids are tiny three-dimensional cellular assemblies that are grown in a laboratory from tissue-specific cells. They are particularly interesting to biologists because of their ability to mimic the characteristics of the original tissues. If scientists extract cells from a tumor, then they can grow cancer organoids that mimic the characteristics of the source tumor. This possibility for individual-level studies of tumor properties makes cancer organoids an exciting tool from the perspective of an emerging field called precision cancer medicine. Daniel Gil of the University of Wisconsin ...

New Barrett's esophagus monitoring method could aid in easier and more precise prognoses

New Barretts esophagus monitoring method could aid in easier and more precise prognoses
2021-03-22
CLEVELAND--A new technique for sampling and testing cells from Barrett's esophagus (BE) patients could result in earlier and easier identification of patients whose disease has progressed toward cancer or whose disease is at high risk of progressing toward cancer, according to a collaborative study by investigators at Case Western Reserve University and Johns Hopkins Kimmel Cancer Center (JHKCC). Published in the journal Gastroenterology, the findings show the combination of esophageal "brushing" with a massively parallel sequencing method can provide an accurate assessment of the ...

Healthy sleep may rely on long-overlooked brain cells

2021-03-22
For something we spend one-third of our lives doing, we still understand remarkably little about how sleep works -- for example, why can some people sleep deeply through any disturbance, while others regularly toss and turn for hours each night? And why do we all seem to need a different amount of sleep to feel rested? For decades, scientists have looked to the behavior of the brain's neurons to understand the nature of slumber. Now, though, researchers at UC San Francisco have confirmed that a different type of brain cell that has received far less study -- astrocytes, named for their star-like shape -- can influence how long and how deeply animals sleep. The findings could open new avenues for exploring sleep disorder therapies and help scientists better understand brain diseases linked ...

Large new study reveals rates of brain abnormalities in healthy children

2021-03-22
A large study of brain MRI scans from 11,679 nine- and ten-year-old children reviewed by UC San Francisco neuroradiologists identified potentially life-threatening conditions in 1 in 500 children, and more minor but possibly clinically significant brain abnormalities in 1 out of 25 children. The results provide the best estimates to date of the true incidence of various structural abnormalities in the developing brain, and raise the question of whether all MRI brain imaging obtained during research studies should be reviewed by board-certified radiologists, as was done in this study, in the hopes of saving lives and alerting participants to incidental findings that ought to be medically evaluated. One ...

Negative mood linked to prolonged amygdala activity

Negative mood linked to prolonged amygdala activity
2021-03-22
How the amygdala responds to viewing negative and subsequent neutral stimuli may impact our daily mood, according to new research published in JNeurosci. The amygdala evaluates the environment to find potential threats. If a threat does appear, the amygdala can stay active and respond to new stimuli like they are threatening too. This is helpful when you are in a dangerous situation, but less so when spilling your coffee in the morning keeps you on edge for the rest of the day. In a recent study, Puccetti et al. examined data collected from the "Midlife ...

New study implicates disease-driving B cells in fatty liver disease development

2021-03-22
MINNEAPOLIS/ST.PAUL (03/22/2021) -- New research from the University of Minnesota Medical School suggests that disease-driving B cells, a white blood cell, play a role in the development of non-alcoholic fatty liver disease (NAFLD) - the most common chronic liver condition in the U.S. Their findings could lead to targeted therapies for NAFLD, which currently affects a quarter of the nation and has no FDA-approved treatments. After noticing that patients with the disease showed a large number of inflammatory B cells in their livers, Xavier Revelo, PhD, an assistant professor in the Department of Integrative Biology and Physiology and senior author, began studying B cells in NAFLD. "This disease is increasing in prevalence ...

Trinity scientists find that binding iron improves the effect of anti-TB drug Bedaquiline

2021-03-22
Although Tuberculosis, or TB, killed nearly as many people as COVID-19 (approx. 1.8 million) in 2020, it did not receive as much media and public attention. The pandemic has proven that transmissible infection is indeed a global issue. TB remains a serious public health concern in Ireland, particularly with the presence of multi-drug resistant types and the numbers of complex cases here continuing to rise, with cases numbering over 300 annually. Science tells us that iron is crucial for daily human function, but it is also an essential element for the survival of ...

Electrode interphase formation

2021-03-22
Batteries charge and recharge--apparently all thanks to a perfect interplay of electrode material and electrolyte. However, for ideal battery function, the solid electrolyte interphase (SEI) plays a crucial role. Materials scientists have now studied nucleation and growth of this layer in atomic detail. According to the study published in the journal Angewandte Chemie, the properties of anions and solvent molecules need to be well balanced. In lithium-ion batteries, the SEI forms at the beginning of the first charging process, when a potential is applied. Elements from the electrolyte deposit on the graphite electrode and form a coating that soon ...

A sense for the unseen: Novel DNA sensor can rapidly detect antibiotic-resistant pathogens

2021-03-22
Antibiotics have revolutionized the field of medicine by making it possible to treat most known microbial diseases today. However, their uncontrolled usage has led to the major global problem of antibiotic resistance. As we continue to exploit antibiotics, sometimes at doses much higher than needed, disease-causing bacteria are rapidly evolving defense strategies to evade them. These drug-resistant bacteria, also known as "superbugs," cause severe infections that are difficult to treat and can eventually be fatal. Methicillin-resistant Staphylococcus aureus (MRSA), a particularly vicious group of superbugs that have developed resistance to the antibiotic methicillin, is a major cause of hospital-acquired infections. Accurate and timely diagnosis ...

Arctic methane release due to melting ice is likely to happen again

Arctic methane release due to melting ice is likely to happen again
2021-03-22
Boulder, Colo., USA: Beneath the cold, dark depths of the Arctic ocean sit vast reserves of methane. These stores rest in a delicate balance, stable as a solid called methane hydrates, at very specific pressures and temperatures. If that balance gets tipped, the methane can get released into the water above and eventually make its way to the atmosphere. In its gaseous form, methane is one of the most potent greenhouse gases, warming the Earth about 30 times more efficiently than carbon dioxide. Understanding possible sources of atmospheric methane is critical for accurately predicting future climate change. In the Arctic Ocean today, ice sheets exert pressure on the ground below them. That pressure diffuses ...

LAST 30 PRESS RELEASES:

Study links rising suicidality among teen girls to increase in identifying as LGBQ

Mind’s eye: Pineal gland photoreceptor’s 2 genes help fish detect color

Nipah virus: epidemiology, pathogenesis, treatment, and prevention

FDA ban on Red Dye 3 and more are highlighted in Sylvester Cancer's January tip sheet

Mapping gene regulation

Exposure to air pollution before pregnancy linked to higher child body mass index, study finds

Neural partially linear additive model

Dung data: manure can help to improve global maps of herbivore distribution

Concerns over maternity provision for pregnant women in UK prisons

UK needs a national strategy to tackle harms of alcohol, argue experts

Aerobic exercise: a powerful ally in the fight against Alzheimer’s

Cambridge leads first phase of governmental project to understand impact of smartphones and social media on young people

AASM Foundation partners with Howard University Medical Alumni Association to provide scholarships

Protective actions need regulatory support to fully defend homeowners and coastal communities, study finds

On-chip light control of semiconductor optoelectronic devices using integrated metasurfaces

America’s political house can become less divided

A common antihistamine shows promise in treating liver complications of a rare disease complication

Trastuzumab emtansine improves long-term survival in HER2 breast cancer

Is eating more red meat bad for your brain?

How does Tourette syndrome differ by sex?

Red meat consumption increases risk of dementia and cognitive decline

Study reveals how sex and racial disparities in weight loss surgery have changed over 20 years

Ultrasound-directed microbubbles could boost immune response against tumours, new Concordia research suggests

In small preliminary study, fearful pet dogs exhibited significantly different microbiomes and metabolic molecules to non-fearful dogs, suggesting the gut-brain axis might be involved in fear behavior

Examination of Large Language Model "red-teaming" defines it as a non-malicious team-effort activity to seek LLMs' limits and identifies 35 different techniques used to test them

Most microplastics in French bottled and tap water are smaller than 20 µm - fine enough to pass into blood and organs, but below the EU-recommended detection limit

A tangled web: Fossil fuel energy, plastics, and agrichemicals discourse on X/Twitter

This fast and agile robotic insect could someday aid in mechanical pollination

Researchers identify novel immune cells that may worsen asthma

Conquest of Asia and Europe by snow leopards during the last Ice Ages uncovered

[Press-News.org] Long-haul COVID: Columbia physicians review what's known